The editors and authors of Biotechnology and the Law have distilled the book's 950 pages and 21 chapters into a fast- paced overview of key legal issues that affect a biotech company through its complex life cycle.
Biotechnology and the Law: A Primer, Part One (Audio CD Package)
In the first session, the panel will start with the fundamentals of corporate structure and other issues in starting up a biotech company. They will cover dos and don'ts of acquiring the key ingredients namely, intellectual property, staff, and financing. The first session concludes with a discussion of research, development and commercial collaborations.
Biotechnology and the Law: A Primer, Part Two (Audio CD Package)
In the second session, the panel provides an overview of the regulatory approval process, explaining how a scientific discovery becomes an approved pharmaceutical or biologic product. Patent counsel sketch out how patent prosecution and litigation unfold and impact the success or failure of a biotech company. Finally, the panel discusses which missteps can lead to litigation and strategies to help minimize and manage these risks. Although primarily focused on U.S. legal issues, the panelists will touch on select aspects of E.U. and other foreign laws that can dramatically affect a biotech company's prospects for success.